Related Experiment Videos
Plasma endothelin-1 levels in Behçet's disease
1Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Clinical Rheumatology
|January 1, 1997
Summary
Plasma endothelin-1 (ET-1) levels are significantly elevated in Behçet's disease (BD) patients compared to healthy individuals. This study measured ET-1 concentrations, finding higher levels in BD, though the clinical implications remain uncertain.
Area of Science:
- Vascular Biology
- Immunology
- Rheumatology
Background:
- Behçet's disease (BD) is a multisystem inflammatory disorder.
- Endothelin-1 (ET-1) is a potent vasoconstrictor peptide produced by endothelial cells.
- The role of ET-1 in the pathogenesis of BD is not fully understood.
Purpose of the Study:
- To investigate plasma endothelin-1 (ET-1) concentrations in patients with Behçet's disease (BD).
- To compare ET-1 levels between BD patients and healthy controls.
- To explore potential correlations between ET-1 levels and clinical parameters in BD.
Main Methods:
- Plasma ET-1 concentrations were quantified using radioimmunoassay.
- The study included 27 patients diagnosed with Behçet's disease.
- Eighteen healthy individuals served as controls.
Main Results:
- Plasma ET-1 concentrations were significantly higher in BD patients (121.15 +/- 11.6 fmol/dl) compared to healthy controls (89.37 +/- 8.03 fmol/dl, p < 0.05).
- Elevated ET-1 levels did not show a correlation with disease duration, gender, or the presence of ocular or articular involvement.
Conclusions:
- Patients with Behçet's disease exhibit significantly increased plasma levels of endothelin-1.
- The precise cause of elevated ET-1 in BD, whether due to increased synthesis from endothelial injury or its contribution to complications, requires further investigation.
- The findings suggest a potential role for ET-1 in the vascular and/or articular manifestations of Behçet's disease.